SECTION A 1) Quality control is procedure by which companies revaluation quality of all factors included in production. On other side, quality assurance is way of keep mistake and fault in production of goods and neglect issues while delivery services to consumers(Gereffi, 2017). Both are the part of quality management that directs on fulfilled quality requirements and providing confidence. 2) Quality management is the action of overseeing all task required to maintain desired level of excellence. There are four main elements such as quality control, assurance, improvement and planning. It is also means total quality management(TQM). It is beneficial for expressing the requirements of new market and reducing cost for increasing profitability. The advantage of TQM is to increase customer satisfaction. 3) Validationisthe procedureof launchingwritten materialinformationdetermining process, and activities carried out in testing(Hilfiker and von Raumer, 2019). Validation protocol is written plan including production equipment. There are many protocols such as Design, installation etc. Design qualification is the check procedure on design to meet specific needs relating to production quality. 4) Documentation is set of writing given on paper, online and Analog media. It is distributed through websites, software goods and online applications. Good documentation practices is term used in pharmaceutical industries to determine standards of created documents. It includes documentation creation, approval, handwritten entries, maintenance, modification and copies of documents. 5) Good clinical practice(GCP) is global quality standards that determines set of standards. GCP involves all aspects of clinical trail. It is planned and carried out until result is reported to trail. Phase 0 is to learn process of drug in body(Lardy-Fontan and et.al., 2016). Phase 1 is to find the best dose of new drug with few side effects. 1
6) Good laboratory practices(GLP) is the set of values deliberate to assure quality and integrity on non-clinical laboratory researches. GLP guidelines in OECD includes organization and personnel, quality assurance program, equipment, reagents and material, test system, performance of study. GLP means to quality system of management controls for research laboratories. 7) Good manufacturing practices(GMP) are the activities needed in relation to conform and control authorization and licensing of manufacture and sale of pharmaceutical goods. Batch processing records(BPR) is derived from Master Production Records that utilize to document particular information for every batch(Steenbeke, Brunelli and Szucs, 2016). It includes cover page, bill of material, equipment list, process testing, manufacturing instruction and review of BPR. 8) The handling of complaints is also sectioned of good manufacturing practices. GMP is the system which handling complaints by some steps such as receiving complaints, technical investigation, corrective measures. In the first step, open channels with regulator and customers to receive information about position of product in market(Lardy-Fontan and et.al., 2016). Then, technical investigation and measures in corrective way. SECTION B 1. Schedule –M discuss about premises, quality control system and quality control laboratories of pharmaceutical products. 2. Record in GMP should be maintain using schedule documentation and records. 3. A written statement of proof is call as a written evidence. 4. Written procedure for all laboratory programme in known as laboratory quality standards. 5. OECP stands for organization for energy conservation and planning. 6. GCP is defined as Good Clinical Practices. 7. ICH stands for International Conference on Harmonization. 8. The four phases of clinical trials include Phase 0, Phase 1, Phase 2, Phase 3. 9. Adverse drug reaction monitoring is called as Pharmacovigilance. 10.Clinical trial Data management is using clinical trials to manage the data of a clinical trial. 2
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
REFERENCES Books and Journals Gereffi, G., 2017.The pharmaceutical industry and dependency in the Third World(Vol. 4964). Princeton University Press. Hilfiker, R. and von Raumer, M., 2019.Polymorphism in the Pharmaceutical Industry: Solid Form and Drug Development. Wiley-Vch. Lardy-Fontan, S. and et.al., 2016. For more reliable measurements of pharmaceuticals in the environment: Overall measurement uncertainty estimation, QA/QC implementation and metrological considerations. A case study on the Seine River.TrAC Trends in Analytical Chemistry.77.pp.76-86. Steenbeke, P. S. G. V. M., Brunelli, F. D. K. S. C. and Szucs, R., 2016. On-Line Two- Dimensional Liquid Chromatography (2D-LC) for the Analysis of Pharmaceuticals. 3